Havana, Cuba

Gryssell Rodriguez Martinez


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gryssell Rodriguez Martinez: Innovator in Vaccine Development

Introduction

Gryssell Rodriguez Martinez is a notable inventor based in Havana, Cuba. He has made significant contributions to the field of immunology, particularly in the development of vaccine compositions for cancer treatment. His innovative approach has the potential to enhance therapeutic options for patients suffering from tumors.

Latest Patents

Gryssell holds a patent for a "Method for making a homogenous vaccine composition comprising a conjugate of EGF and 64K for the treatment of tumors." This vaccine composition is designed for therapeutic use in cancer patients and includes a chemical conjugate of human recombining Epidermic Growth Factor (hrEGF) and a combining protein P64k. The conjugation reaction produces this chemical conjugate in a controlled and reproducible manner. The preferred conjugate surprisingly increases immunogenic activity, leading to significant increases in anti-EGF antibody titers in humans. This innovative vaccine preparation offers more than one type of effective dose presentation, allowing for an increased immunization dose per patient without necessitating an increase in immunization frequency or the number of immunization sites.

Career Highlights

Gryssell is affiliated with the Centro de Inmunología Molecular (CIM), where he continues to advance his research and development efforts. His work is pivotal in the ongoing fight against cancer, and he is recognized for his dedication to improving patient outcomes through innovative vaccine solutions.

Collaborations

Gryssell collaborates with talented colleagues, including Lisel Vina Rodriguez and Loany Calvo Gonzalez. Their combined expertise contributes to the success of their projects and enhances the research environment at CIM.

Conclusion

Gryssell Rodriguez Martinez is a pioneering inventor whose work in vaccine development holds promise for cancer treatment. His innovative methods and collaborative spirit are essential in the quest for effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…